Lucid (LCID) had the highest return on January 29, 2024 by a mid-cap US stock, returning 22.5%.

ASSET	DATE	% RETURN
Lucid (LCID)	1/29/2024	22.55%
American Bitcoin (ABTC)	1/29/2024	20.59%
Dave (DAVE)	1/29/2024	20.16%
Bitdeer Technologies Group Class A Ordinary Shares (BTDR)	1/29/2024	14.23%
Intuitive Machines (LUNR)	1/29/2024	13.81%
Sezzle (SEZL)	1/29/2024	13.46%
Vera Therapeutics (VERA)	1/29/2024	12.7%
Viking Therapeutics (VKTX)	1/29/2024	11.83%
Skeena Resources (SKE)	1/29/2024	11.64%
Nextnav Acquisition (NN)	1/29/2024	10.96%
Immunitybio (IBRX)	1/29/2024	10.94%
Plug Power (PLUG)	1/29/2024	10.82%
Arcutis Biotherapeutics (ARQT)	1/29/2024	10.58%
Novocure (NVCR)	1/29/2024	10.56%
Opendoor Technologies (OPEN)	1/29/2024	9.73%
Cipher Mining (CIFR)	1/29/2024	9.51%
Ocular Therapeutix (OCUL)	1/29/2024	9.42%
Upstart Holdings (UPST)	1/29/2024	9.2%
Nektar Therapeutics (NKTR)	1/29/2024	8.97%
Beam Therapeutics (BEAM)	1/29/2024	8.6%
Eos Energy Enterprises (EOSE)	1/29/2024	8.57%
Travere Therapeutics (TVTX)	1/29/2024	8.12%
QuantumScape Corporation Class A Common Stock (QS)	1/29/2024	7.81%
Definium Therapeutics (DFTX)	1/29/2024	7.77%
Crispr Therapeutics (CRSP)	1/29/2024	7.69%

Mid-cap stocks are treated as having a market cap between $2B and $10B.